Cytokeratin 8/18 is a useful immunohistochemical marker for hepatocellular proliferative lesions in mice

Journal of Veterinary Medical Science

Volumn 72, Issue 3, 2010, Pages 263-269

  Kawai, Masaomi ^a,b   Saegusa, Yukie ^a,b   Kemmochi, Sayaka ^a,b   Harada, Tomoaki ^a   Shimamoto, Keisuke ^a,b   Shibutani, Makoto ^a   Mitsumori, Kunitoshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Cytokeratin 8 18; Liver; Mouse; Piperonyl butoxide

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 18; CYTOKERATIN 8; DIETHYLNITROSAMINE; PIPERONYL BUTOXIDE;

ADENOMA; ANIMAL; ARTICLE; CANCER STAGING; CARCINOMA; CHEMICALLY INDUCED DISORDER; IMMUNOHISTOCHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MOUSE; PATHOLOGY; RAT;

ADENOMA; ANIMALS; BIOLOGICAL MARKERS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; HEPATECTOMY; IMMUNOHISTOCHEMISTRY; KERATIN-18; KERATIN-8; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED ICR; NEOPLASM STAGING; PIPERONYL BUTOXIDE; RATS;

MUS;

EID: 77950364290     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.09-0329     Document Type: Article

References (32)

1. Abe, M. and Oshima, R. G. 1990. A single human keratin 18 gene is expressed in diverse epithelial cells of transgenic mice. J. Cell Biol. 111: 1197-1206.
2. Athanassiadou, P., Psyhoyiou, H., Grapsa, D., Gonidi, M., Ketikoglou, I. and Patsouris, E. 2007. Cytokeratin 8 and 18 expression in imprint smears of chronic viral hepatitis, autoimmune hepatitis and hepatocellular carcinoma. A preliminary study. Acta Cytol. 51: 61-65.
3. Beer, D. G. and Pitot, H. C. 1987. Biological markers characterizing the development of preneoplastic and neoplastic lesions in rodent liver. Arch. Toxicol. (Suppl.) 10: 68-80.
4. Butler, W. H., Gabriel, K. L., Osimitz, T. G. and Preiss, F. J. 1998. Oncogenicity studies of piperonyl butoxide in rats and mice. Hum. Exp. Toxicol. 17: 323-330.
5. Cadrin, M., McFarlane-Anderson, N., Aasheim, L. H., Kawahara, H., Franks, D. J., Marceau, N. and French, S.W. 1992. Differential phosphorylation of CK8 and CK18 by 12-O-tetradecanoylphorbol-13-acetate in primary cultures of mouse hepatocytes. Cell Signal. 4: 715-722.
6. Carter, J. H., Richmond, R. E., Carter, H. W., Potter, C. L., Daniel, F. B. and DeAngelo, A. B. 1992. Quantitative image cytometry of hepatocytes expressing gamma-glutamyl transpeptidase and glutathione S-transferase in diethylnitrosamineinitiated rats treated with phenobarbital and/or phthalate esters. J. Histochem. Cytochem. 40: 1105-1115.
7. Cater, K. C., Gandolfi, A. J. and Sipes, I. G. 1985. Characterization of dimethylnitrosamine-induced focal and nodular lesions in the livers of newborn mice. Toxicol. Pathol. 13: 3-9.
8. Doi, K., Wei, M., Kitano, M., Uematsu, N., Inoue, M. and Wanibuchi, H. 2009. Enhancement of preneoplastic lesion yield by Chios Mastic Gum in a rat liver medium-term carcinogenesis bioassay. Toxicol. Appl. Pharmacol. 234: 135-142.
9. Fiala, S. Fiala, A. E. and Dixon, B. 1972. Gamma-glutamyl transpeptidase in transplantable, chemically induced rat hepatomas and "spontaneous" mouse hepatomas. J. Natl. Cancer Inst. 48: 1393-1401.
10. Fiala, S., Mohindru, A., Kettering, W. G., Fiala, A. E. and Morris, H. P. 1976. Glutathione and gamma glutamyl transpeptidase in rat liver during chemical carcinogenesis. J. Natl. Cancer Inst. 57: 591-598.
11. Fukushima, S., Morimura, K., Wanibuchi, H., Kinoshita, A. and Salim, E. I. 2005. Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens. Toxicol. Appl. Pharmacol. 207: 225-229.
12. Hanigan, M. H. and Pitot, H. C. 1985. Gamma-glutamyl transpeptidase-its role in hepatocarcinogenesis. Carcinogenesis 6: 165-172.
13. Hendrich, S. and Pitot, H. C. 1987. Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis. Cancer Metastasis Rev. 6: 155-178.
14. Ito, N., Tsuda, H., Tatematsu, M., Inoue, T., Tagawa, Y., Aoki, T., Uwagawa, S., Kagawa, M., Ogiso, T., Masui, T., Imaida, K., Fukushima, S. and Asamoto, M. 1988. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats--an approach for a new medium-term bioassay system. Carcinogenesis 9: 387-394.
15. Johnson, D. E., Herndier, B. G., Medeiros, L. J., Warnke, R. A. and Rouse, R. V. 1988. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am. J. Surg. Pathol. 12: 187-197.
16. Kakehashi, A., Inoue, M., Wei, M., Fukushima, S. and Wanibuchi, H. 2009. Cytokeratin 8/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas. Toxicol. Appl. Pharmacol. 238: 71-79.
17. Kato, K., Uchida, K., Nibe, K. and Tateyama, S. 2007. Immunohistochemical studies on cytokeratin 8 and 18 expressions in canine cutaneous adnexus and their tumors. J. Vet. Med. Sci. 69: 233-239.
18. Kawai, M., Jin, M., Nishimura, J., Dewa, Y., Saegusa, Y., Matsumoto, S., Taniai, E., Shibutani, M. and Mitsumori, K. 2008. Hepatocarcinogenic susceptibility of fenofibrate and its possible mechanism of carcinogenicity in a two-stage hepatocarcinogenesis model of rasH2 mice. Toxicol. Pathol. 36: 950-957.
19. Kawai, M., Saegusa, Y., Jin M., Dewa, Y., Nishimura, J., Harada, T., Shibutani, M. and Mitsumori, K. 2009. Mechanistic study on hepatocarcinogenesis of piperonyl butoxide in mice. Toxicol. Pathol. 37: 761-769.
20. Ku, N. O., Darling, J. M., Krams, S. M., Esquivel, C. O., Keeffe, E. B., Sibley, R. K., Lee, Y. M., Wright, T. L. and Omary, M. B. 2003. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc. Natl. Acad. Sci. U.S.A. 100: 6063-6068.
21. Kushida, M., Sukata, T., Uwagawa, S., Ozaki, K., Kinoshita, A., Wanibuchi, H., Morimura, K., Okuno, Y. and Fukushima, S. 2005. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms. Toxicol. Appl. Pharmacol. 208: 285-294.
22. Lau, A. T. and Chiu, J. F. 2007. The possible role of cytokeratin 8 in cadmium-induced adaptation and carcinogenesis. Cancer Res. 67: 2107-2113.
23. Moto, M., Okamura, M., Muguruma, M., Ito, T., Jin, M., Kashida, Y. and Mitsumori, K. 2006. Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice. Toxicol. Pathol. 34: 744-751.
24. Omary, M. B., Ku, N. O. and Toivola, D. M. 2002. Keratins: guardians of the liver. Hepatology 35: 251-257.
25. Pitot, H. C., Glauert, H. P. and Hanigan, M. 1985. The significance of selected biochemical markers in the characterization of putative initiated cell populations in rodent liver. Cancer Lett. 29: 1-14.
26. Popp, J. A. and Goldsworthy, T. L. 1989. Defining foci of cellular alteration in shortterm and medium-term rat liver tumor models. Toxicol. Pathol. 17: 561-568.
27. Rutenburg, A. M., Kim, H., Fischbein, J. W., Hanker, J. S., Wasserkrug, H. L. and Seligman, A. M. 1969. Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity, J. Histochem. Cytochem. 17: 517-525.
28. Sato, K., Kitahara, A., Satoh, K., Ishikawa, T., Gtematsu, M. and Ito, N. 1984. The placental form of glutathione-s-transrase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. Jpn. J. Cancer Res. 75: 199-202.
29. Takahashi, O., Oishi, S., Fujitani, T., Tanaka, T. and Yoneyama, M. 1994. Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma. Fundam. Appl. Toxicol. 22: 293-303.
30. Tatematsu, M., Mera, Y., Ito, N., Satoh, K. and Sato, K. 1985. Relative merits of immunohistochemical demonstrations of placental, A, B and C form of glutathione-s-transferase and histochemical demonstrations of gammaglutamyl transferase as markers of altered foci: during liver carcinogenesis in rats. Carcinogenesis 6: 1621-1626.
31. Thompson, G. A. and Meister, A. 1979. Modulation of the hydrolysis, transfer, and glutaminase activities of gammaglutamyl transpeptidase by maleate bound at the cysteinylglycine binding site of the enzyme. J. Biol. Chem. 254: 2956-2960.
32. Zhou, Q., Ji, X., Chen, L., Greenberg, H. B., Lu, S. C. and Omary, M. B. 2005. Keratin mutation primes mouse liver to oxidative injury. Hepatology 41: 517-525.